|
End-of-day quote
Shanghai S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 13.18 CNY | -2.08% |
|
-2.23% | +12.65% |
| 08-27 | Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 05-26 | Guizhou Sanli Pharmaceutical to Raise Up to 700 Million Yuan in Private Placement | MT |
| Market Cap | 5.33B 796M 709M 661M 602M 1.13B 76.69B 1.15B 8.01B 3.11B 39.17B 2.99B 2.92B 126B | P/E 2024 |
19.4x | P/E 2025 | 106x |
|---|---|---|---|---|---|
| Enterprise Value | 5.68B 848M 755M 704M 642M 1.21B 81.7B 1.22B 8.53B 3.31B 41.73B 3.19B 3.12B 134B | EV / Sales 2024 |
2.48x | EV / Sales 2025 | 2.99x |
| Free-Float |
40.62% | Yield 2024 |
2.62% | Yield 2025 | 0.51% |
| 1 day | -2.08% | ||
| 1 week | -2.23% | ||
| 1 month | +9.02% | ||
| 3 months | -2.30% | ||
| 6 months | +16.23% | ||
| Current year | +12.65% |
| 1 week | 13.12 |  | 13.77 |
| 1 month | 10.91 | | 15.17 |
| Current year | 9.51 | | 17.46 |
| 1 year | 9.51 | | 17.46 |
| 3 years | 9.51 | | 20.34 |
| 5 years | 9.51 | | 21.28 |
| 10 years | 8.82 | | 44.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Qian Fan Zhang
CEO | Chief Executive Officer | 41 | 2024-05-26 |
Hai Zhang
CEO | Chief Executive Officer | 41 | 2011-08-31 |
Ke Guo
DFI | Director of Finance/CFO | 39 | 2024-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Hai Zhang
CHM | Chairman | 41 | 2018-02-28 |
Qian Fan Zhang
BRD | Director/Board Member | 41 | 2018-02-28 |
Yong Jian Sheng
BRD | Director/Board Member | 52 | 2015-01-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/11/24 | Sell | Chief Executive Officer | 21,000,000 | 5.1428% | ||
| 8/2/24 | Buy | Director | 13,000 | 0.0032% | ||
| 8/5/23 | Sell | 25,000 | 0.0061% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.08% | -2.23% | +4.19% | -25.96% | 795M | |
| -0.61% | -3.30% | +38.46% | +112.77% | 1,025B | |
| -1.02% | -5.41% | +37.61% | +64.39% | 623B | |
| +1.11% | -0.87% | +7.55% | +76.32% | 459B | |
| +0.34% | -2.49% | +60.10% | +40.17% | 355B | |
| -0.95% | -4.87% | +22.46% | +38.03% | 336B | |
| -1.46% | -2.20% | +11.84% | +23.94% | 270B | |
| -1.35% | -4.27% | -4.55% | +6.92% | 247B | |
| -1.04% | -0.74% | +35.02% | +49.96% | 220B | |
| -1.87% | -3.31% | +30.22% | +93.14% | 183B | |
| Average | -0.51% | -2.21% | +24.29% | +47.97% | 371.9B | |
| Weighted average by Cap. | -0.12% | -2.11% | +29.72% | +68.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 320M 285M 266M 242M 455M 30.83B 460M 3.22B 1.25B 15.75B 1.2B 1.18B 50.52B | 1.7B 254M 226M 211M 192M 361M 24.48B 366M 2.56B 991M 12.5B 954M 934M 40.12B |
| Net income | 274M 40.91M 36.41M 33.94M 30.94M 58.17M 3.94B 58.83M 411M 160M 2.01B 154M 150M 6.46B | 46.25M 6.9M 6.15M 5.73M 5.22M 9.82M 665M 9.93M 69.45M 26.93M 340M 25.92M 25.36M 1.09B |
| Net Debt | 108M 16.07M 14.31M 13.34M 12.16M 22.85M 1.55B 23.12M 162M 62.68M 791M 60.34M 59.03M 2.54B | 349M 52.06M 46.34M 43.19M 39.38M 74.02M 5.01B 74.87M 524M 203M 2.56B 195M 191M 8.22B |
Employees
1,887
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | CN¥13.18 | -2.08% | 10,006,600 |
| 26-09-29 | CN¥13.46 | +0.15% | 10,598,300 |
| 26-09-28 | CN¥13.44 | -0.30% | 14,287,981 |
| 26-09-24 | CN¥13.48 | -2.88% | 11,863,700 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 603439 Stock
Select your edition
All financial news and data tailored to specific country editions
